LFCR · Lifecore Biomedical, Inc. De · Financials
Market Cap
$156.90M
Shares
37.85M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$128.87M
+0.5%
FY2025
Net Income
-$38.72M
-422.3%
FY2025
Gross Margin
31.27%
-1.4pp
FY2025
Operating Margin
-13.38%
-6.5pp
FY2025
Diluted EPS
-$1.27
-484.8%
FY2025
Operating Cash Flow
-$206K
-180.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2029 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $212M – $225M | — | $128.87M | $128.26M | $103.27M | $111.27M | $100.87M | $160.07M | $557.56M | $524.23M | $469.78M | $476.92M | $539.26M | $476.81M | $441.71M | $317.55M | $276.73M | $238.22M | |
| — | — | $88.57M | $86.41M | $75.28M | $72.2M | $61.94M | $120.68M | $476.56M | $445.89M | $390.56M | $410.14M | $473.85M | $414.25M | $378.95M | $265.41M | $230.03M | $204.46M | |
| — | — | $40.3M | $41.85M | $27.99M | $39.07M | $38.94M | $39.39M | $81M | $78.34M | $79.21M | $66.78M | $65.41M | $62.56M | $62.76M | $52.14M | $46.7M | $33.77M | |
| — | — | 31.27% | 32.63% | 27.1% | 35.11% | 38.6% | 24.61% | 14.53% | 14.94% | 16.86% | 14% | 12.13% | 13.12% | 14.21% | 16.42% | 16.87% | 14.17% | |
| — | — | $8.26M | $8.58M | $8.74M | $7.84M | $6.68M | $7.58M | $11.47M | $12.8M | $9.47M | $7.23M | $6.99M | $7.2M | $9.29M | $9.63M | $9.28M | $4.36M | |
| — | — | $44.05M | $40.46M | $38.97M | $34.66M | $27.72M | $40.67M | $62.06M | $51.95M | $52.49M | $46.18M | $39.96M | $35.17M | $32.53M | $26.52M | $24.61M | $17.7M | |
| — | — | — | $0 | $0 | $300K | $300K | $1.5M | $1.5M | $1M | $900K | $867K | $885K | -$886K | -$951K | -$309K | $308K | — | |
| — | — | $8.03M | $7.95M | $13.18M | $18.06M | $19.87M | $18.84M | $15.23M | $12.41M | $10.68M | $9.4M | $7.09M | $7.11M | $7.3M | $5.62M | $5.31M | $3.36M | |
| — | — | -$1.75M | $1.66M | $4.18M | $8.36M | $13.36M | $4.05M | $0 | $0 | — | — | — | — | — | — | — | — | |
| — | $57.93M | — | $50.69M | $49.78M | $50.86M | $47.76M | $65.26M | $75.53M | $64.75M | $64.54M | $87.41M | $46.95M | $42.37M | $37.89M | $37.56M | $38.66M | $25.78M | |
| — | — | -$17.25M | -$8.84M | -$21.8M | -$11.79M | -$8.82M | -$25.88M | $5.48M | $13.59M | $14.67M | -$20.63M | $18.46M | $20.19M | $24.87M | $14.58M | $8.03M | $7.98M | |
| — | — | -13.38% | -6.9% | -21.11% | -10.6% | -8.75% | -16.17% | 0.98% | 2.59% | 3.12% | -4.33% | 3.42% | 4.23% | 5.63% | 4.59% | 2.9% | 3.35% | |
| — | — | -$9.22M | -$890K | -$8.62M | $6.27M | $11.04M | -$7.04M | $20.71M | $26M | $25.35M | -$11.23M | $25.55M | $27.3M | — | $20.2M | $13.35M | $11.35M | |
| — | — | — | — | $17.65M | $15.55M | $8.93M | $4.65M | — | — | — | $1.99M | $1.83M | $1.65M | $2.01M | $929K | $820K | $88K | |
| — | — | $333K | $58K | $68K | $81K | $48K | $72K | $145K | $211K | $16K | $71K | $315K | $260K | $179K | $180K | $430K | $834K | |
| — | — | -$3000 | -$3.05M | -$1.16M | $760K | -$10.97M | -$195K | $1.6M | $2.9M | $900K | $1.2M | $3.11M | $10M | $8.1M | $5.33M | $472K | — | |
| — | — | -$38.67M | $9.51M | -$63.93M | -$20.69M | -$29.79M | -$30.65M | $3.64M | $16.4M | $14.18M | -$19.69M | $21.47M | — | $32.26M | $20.28M | $8.44M | $8.73M | |
| — | — | $43K | $183K | $308K | -$5.21M | -$6.35M | -$8.77M | $1.52M | -$9.36M | $4.04M | -$7.7M | $7.75M | $10.58M | $9.45M | $7.19M | $4.18M | -$4.26M | |
| — | — | -$38.72M | $12.01M | -$99.56M | -$116.72M | -$32.29M | -$38.19M | $411K | $24.83M | $10.59M | -$11.64M | $13.54M | $19.15M | $22.59M | $12.7M | $3.92M | $3.98M | |
| — | — | -30.04% | 9.37% | -96.41% | -104.89% | -32.01% | -23.86% | 0.07% | 4.74% | 2.25% | -2.44% | 2.51% | 4.02% | 5.11% | 4% | 1.42% | 1.67% | |
| — | — | — | — | — | — | — | $0 | $0 | $94K | $87K | $193K | $181K | $197K | $225K | $403K | $341K | $482K | |
| — | — | -$44.36M | $12.01M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | $12.01M | -$98.98M | -$115.94M | -$30.84M | -$41.06M | -$673K | $25.55M | — | -$11.64M | $13.54M | $19.15M | $22.59M | $12.7M | — | — | |
| USD/shares | — | — | -$1.27 | $0.39 | -$3.32 | -$3.97 | -$1.10 | -$1.31 | $0.01 | $0.90 | $0.39 | -$0.43 | $0.50 | $0.72 | $0.87 | $0.49 | $0.15 | $0.15 |
| USD/shares | — | — | -$1.27 | $0.33 | -$3.32 | -$3.97 | -$1.10 | -$1.31 | $0.01 | $0.89 | $0.38 | -$0.43 | $0.50 | $0.71 | $0.85 | $0.49 | $0.15 | $0.15 |
| shares | — | — | 34.82M | 30.47M | 29.96M | 29.47M | 29.29M | 29.16M | 28.36M | 27.54M | 27.28M | 27.04M | 26.88M | 26.63M | 25.83K | 25.85M | 26.4M | 26.38K |
| shares | — | — | 34.82M | 36.66M | 29.96M | 29.47M | 29.29M | 29.16M | 28.61M | 27.92M | 27.65M | 27.04M | 27.34M | 27.12M | 26.63K | 26.13M | 26.63M | 26.63K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2011–FY2012: $6.19M in buybacks.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.39×
EV/EBIT
—
Peer median 13.07×
P/E (TTM)
—
Peer median 13.59×
Peer medians compare against the 50 similar-size Drug Manufacturers - Specialty & Generic companies (of 100 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Reportable Segment | $128,867,000 | $128,261,000 | — | — | — | — | — |
| Curation Foods | — | — | $76,466,000 | $73,459,000 | $74,233,000 | $481,686,000 | $458,800,000 |
| Lifecore | — | — | $109,320,000 | $98,087,000 | $85,833,000 | $75,873,000 | $65,427,000 |
| All Other Segments | — | — | $0 | $0 | $0 | $0 | $0 |
By Geography (USD)
| Component | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Switzerland | $16,800,000 | $4,700,000 | $1,700,000 | $1,200,000 | — |
| Canada | $12,600,000 | $10,700,000 | $9,700,000 | $83,600,000 | $78,000,000 |
| Czechia | $3,500,000 | $3,500,000 | $1,400,000 | $0 | — |
| United Kingdom | $2,900,000 | $1,900,000 | $1,100,000 | — | — |
| Ireland | $2,200,000 | $2,000,000 | $4,000,000 | $5,000,000 | $4,100,000 |
| All Other Countries | $2,000,000 | $1,900,000 | $2,200,000 | $3,900,000 | $3,600,000 |
| Belgium | $0 | $13,700,000 | $13,800,000 | $15,100,000 | $17,200,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Contract Development and Manufacturing Organization | $90,095,000 | $96,616,000 | — | — | — | — | — | — |
| HA Manufacturing | $38,772,000 | $31,645,000 | — | — | — | — | — | — |
| Avocado Products | — | — | — | — | $0 | $62,194,000 | $27,322,000 | $0 |
| Contract Development And Manufacturing Organization And Fermentation | — | — | — | — | $98,579,000 | — | — | — |
| Contract Development And Manufacturing Organization | — | — | $76,378,000 | $86,353,000 | $75,789,000 | $64,781,000 | $54,439,000 | $44,359,000 |
| Fermentation | — | — | — | — | $22,790,000 | $21,052,000 | $21,434,000 | $21,068,000 |
| Fresh Packaged Salads and Vegetables | — | — | — | — | — | $7,783,000 | $453,182,000 | $457,124,000 |
| HA Manufacturing Fermentation | — | — | $26,891,000 | $23,007,000 | — | — | — | — |
| Oil And Vinegars | — | — | — | — | $0 | — | — | — |
| Technology | — | — | — | — | — | $4,256,000 | $1,182,000 | $1,676,000 |
| Technology Product | — | — | — | — | $2,295,000 | — | — | — |
| Product And Service Other | — | — | $0 | $1,910,000 | $2,295,000 | — | — | — |
Key facts
CIK
1005286
CUSIP
514766104
13F (30d)
66 filings
66 filers
Visit website
Investor relations